Enable Injections
Latest round
- Series C
Last raised
- Jan 2022
Total raised
- $206M
Investors
- 12
About Enable Injections
Enable Injections, Inc. specializes in innovative drug delivery solutions with its enFuse platform, designed to facilitate convenient subcutaneous administration of medications, particularly for oncology patients. Founded in 2010 and headquartered in Ohio, US, Enable Injections, Inc. focuses on the development of its enFuse platform for drug delivery. The company has undergone a strategic pivot towards partnerships with pharmaceutical companies to enhance its market presence. Mike Hooven leads as CEO and has a history of entrepreneurship in health technology.Enable Injections specializes in the development and manufacturing of the enFuse, an innovative wearable drug delivery platform that allows for the subcutaneous administration of large volumes of medication. This hands-free technology enables patients to receive their treatments through simple site injections under the skin, enhancing convenience and comfort. The enFuse platform addresses the needs of patients requiring ongoing medication, particularly in oncology, and has been recognized for its advanced capabilities.Enable Injections generates revenue through strategic collaborations with pharmaceutical partners for the development and commercialization of their enFuse technology. The company operates a partnership model, engaging with clients who provide medications compatible with the enFuse platform. Revenue is structured around joint agreements that may include shared revenue from sales of therapies utilizing the enFuse injector. Specific pricing plans are not disclosed, but the revenue model aligns with traditional B2B transactions as well as direct-to-consumer scenarios for ongoing patient needs. In January 2026, Enable Injections, Inc.
Who invested in Enable Injections
12 investors across 5 rounds
See all investors in Enable Injections
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Enable Injections
Who invested in Enable Injections?
Enable Injections has 12 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Enable Injections raised?
Enable Injections has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did Enable Injections last raise money?
Enable Injections's most recent round on record is a Series C, in Jan 2022.
What does Enable Injections do?
Enable Injections is a medical devices & equipment company.
Where is Enable Injections headquartered?
Enable Injections is headquartered in Cincinnati, US.
Which VCs invest in companies like Enable Injections?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back medical devices & equipment companies at Enable Injections's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series C
Raising like Enable Injections? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.